Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Core Insights - Absci Corporation (NASDAQ: ABSI) is positioned as a promising biotech company at the intersection of AI and Synthetic Biology, which could accelerate drug discovery processes [1] Company Overview - Absci utilizes AI technology to generate antibodies, leveraging its extensive capabilities in synthetic biology [1]